课题基金 / 基金详情

How Do Colorectal Cancers Arise Despite Surveillance?

How Do Colorectal Cancers Arise Despite Surveillance?
尽管有监测,结直肠癌是如何发生的?
批准号:
7256986
负责人:
Darryl K Shibata
金额:
$23.26万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2010-06-30

项目摘要

项目成果

Darryl K Shibata的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Colorectal cancers are widely believed to develop through an adenoma-cancer sequence. By this paradigm, all cancers should be preventable with surveillance and polypectomy. However, in most surveillance studies, some cancers inevitably appear only a few years after negative clinical examinations. It is uncertain how such "interval" cancers appear, but either an adenoma was missed during the last "negative" examination, or there was an unexpected "rapid" mode of progression. A large number of such interval cancers have been found during an ongoing clinical surveillance program of high risk individuals with germline mutations in DNA mismatch repair genes (MMR), or hereditary nonpolyposis colorectal cancer (HNPCC). These interval cancers provide unique opportunities to rigorously understand why prevention fails. The key emerging technology is a new capability that infers time from cancer mutations. A molecular tumor clock can quantitatively infer times since MMR loss, and ages of final cancer expansions---the more mutations in a cancer, the greater these intervals. Distinguishing between failure from inadequate surveillance ("missed adenomas"), and failure due to the unique biology of HNPCC colorectal cancers ("rapid histologic or genetic progression"), is critical for the development of more effective strategies to prevent and treat colorectal cancer.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Older individuals appear to acquire mitotically older colorectal cancers.
老年人似乎会患上有丝分裂较老的结直肠癌。
DOI: 10.1002/path.2506
发表时间: 2009
期刊: The Journal of pathology
影响因子: --
作者: [Woo,Yen-Jung, Siegmund,KimberlyD, Tavaré,Simon, Shibata,Darryl]
通讯作者: Shibata,Darryl
Photolithographic Tumor DNA Isolation
  • 批准号:
    10670402
  • 项目类别:
  • 资助金额:
    $18.14万
  • 财政年份:
    2022
  • 负责人:
    Darryl K Shibata
  • 依托单位:
Photolithographic Tumor DNA Isolation
  • 批准号:
    10495070
  • 项目类别:
  • 资助金额:
    $22.73万
  • 财政年份:
    2022
  • 负责人:
    Darryl K Shibata
  • 依托单位:
Project 2: Normal Cell Evolution
Project 3: Neoplastic Cell Evolution
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: